Literature DB >> 8450646

Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.

R Appasamy1, M Tanabe, N Murase, R Zarnegar, R Venkataramanan, D H Van Thiel, G K Michalopoulos.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) (also known as scatter factor (SF)) is a heterodimeric protein that is the most potent known complete mitogen for hepatocytes in culture. HGF is a mitogen for many epithelial cells including hepatocytes, kidney tubular epithelial cells, mammary epithelial cells, keratinocytes, etc. The protein encoded by the proto-oncogene c-met is the high affinity receptor for HGF. HGF concentration in the plasma dramatically increases after partial hepatectomy and in fulminant hepatic failure. This study describes the pharmacokinetics of HGF in the rat. EXPERIMENTAL
DESIGN: Human recombinant HGF (a gift from Genentech) was radioiodinated and shown to retain biologic activity and structure. Approximately 74 ng of [125I]HGF was injected into the penile vein of male Fisher rats 5 minutes after a complete bile fistula and jugular venous catheterization were performed for blood and bile sampling. Half of the rats were subjected to 70% partial hepatectomy.
RESULTS: The percentage of injected radioactivity present in the liver of control rats was 29.5% +/- 0.5% at 15 minutes and decreased to 8.6% +/- 1.0% at 120 minutes; the kidneys had 6.2% +/- 0.2% at 15 minutes, decreasing to 1.48% +/- 0.3% at 120 minutes. All the other organs examined had less than 1% of the injected radioactivity. The remaining radioactivity was present in low affinity sites in blood, bone, muscle, and skin. In control rats, radioactivity appeared in the bile within 3 minutes, reached a peak between 40 to 50 minutes, and tapered thereafter for a total 2-hour collection of 2.3% +/- 0.5%. In the partially hepatectomized rats, the HGF blood clearance was decreased (partial hepatectomy = 0.27 +/- 0.03 ml/minute; control = 0.53 +/- 0.06 ml/minute, p < 0.006), and the terminal half-life prolonged (partial hepatectomy = 124 +/- 11 minutes; control = 83 +/- 10 minutes, p < 0.03). The initial half-life for HGF, as extrapolated from the chart, was estimated at 3.8 minutes in control rats.
CONCLUSIONS: Liver is the principle organ for initial uptake of [125I]HGF; disappearance from the blood suggests multicompartment kinetics with a rapid phase and a slower phase; only a portion of the hepatic uptake appears in the bile; and partial hepatectomy decreases the blood clearance of [125I]HGF. These results are correlated with previous findings bearing on the role of HGF elevation after partial hepatectomy as a stimulus for transfer of hepatocytes from G0 to G1 early in liver regeneration after partial hepatectomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450646

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  22 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 2.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 3.  Understanding the marvels behind liver regeneration.

Authors:  Anan Abu Rmilah; Wei Zhou; Erek Nelson; Li Lin; Bruce Amiot; Scott L Nyberg
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-03-28       Impact factor: 5.814

4.  Hepatocyte Growth Factor-Secreting Mesothelial Cell Sheets Suppress Progressive Fibrosis in a Rat Model of CKD.

Authors:  Masatoshi Oka; Sachiko Sekiya; Ryoichi Sakiyama; Tatsuya Shimizu; Kosaku Nitta
Journal:  J Am Soc Nephrol       Date:  2019-01-11       Impact factor: 10.121

5.  Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.

Authors:  P Harrison; C Gove; A Bomford
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

6.  Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor.

Authors:  Kazuhiro Fukuta; Kunio Matsumoto; Toshikazu Nakamura
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

7.  Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

Authors:  M L Liu; W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Microfluidic confinement enhances phenotype and function of hepatocyte spheroids.

Authors:  Jong Hoon Choi; Lorena Loarca; Jose M De Hoyos-Vega; Neda Dadgar; Kevin Loutherback; Vijay H Shah; Gulnaz Stybayeva; Alexander Revzin
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-22       Impact factor: 4.249

Review 9.  Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair.

Authors:  Rachel N Frisch; Kevin M Curtis; Kristina K Aenlle; Guy A Howard
Journal:  Expert Opin Ther Targets       Date:  2016-03-21       Impact factor: 6.902

10.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.